If you can’t beat them, cry about them. the chairman of Sanofi-Aventis of France recently complained that generic drug companies were making product in poor countries where costs were low and then selling the drugs in wealthier companies at a profit.
Big pharman executives need to be a little more careful about what they say, lest it be turned back on them. There is a broad perception that these companies with their patented drugs to fair too little to supply them to the poor in underdeveloped countries. Strong enforcment of their patents, and, therefore, profits make the issue of inexpensive therapies all the more acute.
Off the soap-box before someone pushes you.
Douglas A. McIntyre can be reached at [email protected]. He does not own securities in companies that he writes about.
Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the
advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
